Clinical Trials Logo

Endothelial Dysfunction clinical trials

View clinical trials related to Endothelial Dysfunction.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 2

NCT ID: NCT03255408 Not yet recruiting - Stroke Clinical Trials

Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia

Start date: January 1, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

A prospective double blind, placebo-controlled, randomized cross-over trial to evaluate the effect of lowering cerebral blood flow on the ventilatory chemoreflexes (acute hypoxic and hypercapnic ventilatory responses).

NCT ID: NCT03188913 Not yet recruiting - Burns Clinical Trials

Factor XIII in Major Burns Coagulation

Start date: June 19, 2017
Phase: N/A
Study type: Observational

Prospective observational study in which FXIII levels and coagulation tests and cicatrization are measured during the 30 days after the thermal trauma.

NCT ID: NCT02206919 Not yet recruiting - Diabetes Clinical Trials

Magnetic Resonance Imaging of Vascular Function

Start date: June 2014
Phase: N/A
Study type: Observational

A major function of blood vessels is to control blood flow by dilating or constricting depending on the demand. Vascular dysfunction is a state in which blood vessels fail to carry out its normal roles such as regulating blood flow. Diabetes is a risk factor for vascular dysfunction. Dysfunction may involve the smaller and/or larger blood vessels. Failure in the ability of large (conduit) blood vessels to control blood flow may be an early feature of atherosclerosis, a leading cause of stroke and heart attack. Measures of blood vessel dilation give an indication of the health of the vessel. Ultrasound and MRI can assess vascular function by measuring changes in blood vessel dilation. Diabetes may also affect tiny vessels in the kidney. These vessels become porous allowing albumin (a protein in the blood) to leak into the urine. The investigators can easily measure the presence of albumin in the urine. This study aims to explore if MRI can demonstrate an association between vascular health in tiny and larger (conduit) blood vessels, by testing for an association between blood flow regulatory capacity of large vessels and presence of albumin in the urine.

NCT ID: NCT01771406 Not yet recruiting - Hypertension Clinical Trials

CPAP and Nebivolol in Hypertensive Obstructive Sleep Apnea (OSA) Patients.

NEBOSA
Start date: February 2013
Phase: Phase 4
Study type: Interventional

The aim of this study is to examine how effective CPAP treatment and treatment with nebivolol are respectively on reducing blood pressure and on endothelial dysfunction in patients suffering from obstructive sleep apnea and hypertension.

NCT ID: NCT01502826 Not yet recruiting - Inflammation Clinical Trials

Mechanisms of Atherogenesis During Post-prandial Time in Childhood Obesity

Start date: February 2012
Phase: N/A
Study type: Observational

Childhood obesity is increasing at a fast pace, together with its complications. The aim of the present study is to assess several candidate triggering agents, mechanisms and intermediate phenotypes of atherosclerosis during the post-prandial phase in the obese insulin-resistant child/adolescent.

NCT ID: NCT00808535 Not yet recruiting - Diabetes Clinical Trials

Cardiac Magnetic Resonance Imaging for Detecting Endothelial Dysfunction

Start date: February 2009
Phase: N/A
Study type: Observational

The goal of this research study is to demonstrate that Cardiac Perfusion MRI with Vasomotor Stress may serve as a non-invasive and less risky imaging technique for detecting non-obstructive perfusion deficits and/or abnormalities in myocardial blood flow (MBF) in patients with endothelial dysfunction. This is a controlled study, which will enroll approximately 60 subjects (30 diabetics and 30 non-diabetics to serve as healthy controls), and will include male and non-pregnant females, between the ages 18-50 years. All eligible participants will sign an informed consent and will complete a Lifestyle Questionnaire. They will undergo blood work which includes: - 2-hour Oral Glucose Tolerance Test and Fasting Labs for Glucose, Insulin, C-Peptide, HbA1c, Creatinine, and Lipid Panel. - Urine Albumin to Creatinine ratio for microalbuminuria. - Serum inflammatory markers: E-selectin, homocysteine, ADMA, VCAM, IL-6, TNFalpha, hs-CRP and PAI-1. After blood work, all participants will undergo cardiac MR perfusion imaging procedure with Cold Pressor Test and Adenosine Stress Test.